{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:50:44Z","timestamp":1790743844812,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1007\/s11926-996-0007-5","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T11:18:19Z","timestamp":1180783099000},"page":"379-386","source":"Crossref","is-referenced-by-count":58,"title":["Juvenile dermatomyositis: The association of the TNF\u03b1-308A Allele and disease chronicity"],"prefix":"10.1007","volume":"3","author":[{"given":"Lauren M.","family":"Pachman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara O.","family":"Fedczyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toula S.","family":"Lechman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennica","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"7_CR1","first-page":"679","volume":"43","author":"E Mendez","year":"1999","unstructured":"Mendez E, Lipton RB, Dyer A, et al.: Incidence of juvenile dermatomyositis (JDM) in the USA: results from a NIAMS JDM Research Registry. Arthritis Rheum 1999, 43:679.","journal-title":"Arthritis Rheum"},{"key":"7_CR2","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/1529-0131(200010)43:10<2368::AID-ANR26>3.0.CO;2-8","volume":"43","author":"LM Pachman","year":"2000","unstructured":"Pachman LM, Liotta-Davis MR, Hong DK, et al.: TNFa-308A allele in juvenile dermatomyositis\u2014associations with increased TNFa production, disease duration, and pathological calcifications. Arthritis Rheum 2000, 43:2368\u20132377. Report of a genetic association with chronic disease in juvenile dermatomyositis.","journal-title":"Arthritis Rheum"},{"key":"7_CR3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB: Polymyositis and dermatomyositis (parts 1 and 2). N Engl J Med 1975, 292:344\u2013347; 403\u2013407. Provides the classic criteria for case definition.","journal-title":"N Engl J Med"},{"key":"7_CR4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2214\/ajr.161.2.8333378","volume":"161","author":"RJ Hernandez","year":"1993","unstructured":"Hernandez RJ, Sullivan DB, Chenevert TL: MR imaging in children with dermatomyositis: musculoskeletal findings and correlation with clinical and laboratory findings. AJR 1993, 161:359\u2013366.","journal-title":"AJR"},{"key":"7_CR5","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/1529-0131(200010)43:10<2368::AID-ANR26>3.0.CO;2-8","volume":"43","author":"LM Pachman","year":"2000","unstructured":"Pachman LM, Fedczyna TO, Lutz JL, et al.: Increased CD8+and CD56+ lymphocytes in untreated juvenile dermatomyositis (JDM) muscle biopsies (MBx) are associated with a short compared with a long disease duration. Arthritis Rheum 2000, 43:772.","journal-title":"Arthritis Rheum"},{"key":"7_CR6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","volume":"70","author":"LA Love","year":"1991","unstructured":"Love LA, Leff RL, Fraser DD, et al.: A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991, 70:360\u2013374.","journal-title":"Medicine (Baltimore)"},{"key":"7_CR7","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/art.1780371019","volume":"37","author":"LG Rider","year":"1994","unstructured":"Rider LG, Miller FW, Targoff IN, et al.: A broadened spectrum of juvenile myositis: myositis-specific autoantibodies in children. Arthritis Rheum 1994, 37:1534\u20131538.","journal-title":"Arthritis Rheum"},{"key":"7_CR8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0889-857X(05)70350-1","volume":"23","author":"LG Rider","year":"1997","unstructured":"Rider LG, Miller FW: Classification and treatment of the juvenile idiopathic inflammatory myopathies. Rheum Dis Clin North Am 1997, 23:619\u2013655. A good review of classification and treatment of juvenile dermatomyositis.","journal-title":"Rheum Dis Clin North Am"},{"key":"7_CR9","first-page":"1794","volume":"23","author":"BM Feldman","year":"1996","unstructured":"Feldman BM, Reichlin M, Laxer RM, et al.: Clinical significance of specific autoantibodies in juvenile dermatomyositis. J Rheumatol 1996, 23:1794\u20131797.","journal-title":"J Rheumatol"},{"key":"7_CR10","first-page":"395","volume":"25","author":"S Roux","year":"1998","unstructured":"Roux S, Seelig HP, Meyer O: Significance of Mi-2 autoantibodies in polymyositis and dermatomyositis [letter]. J Rheumatol 1998, 25:395\u2013396.","journal-title":"J Rheumatol"},{"key":"7_CR11","first-page":"263","volume":"14","author":"YM Maugars","year":"1996","unstructured":"Maugars YM, Berthelot JM, Abbas AA, et al.: Long-term prognosis of 69 patients with dermatomyositis or polymyositis. Clin Exp Rheumatol 1996, 14:263\u2013274.","journal-title":"Clin Exp Rheumatol"},{"key":"7_CR12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00007611-199801000-00003","volume":"91","author":"CH Collison","year":"1998","unstructured":"Collison CH, Sinal SH, Jorizzo JL, Walker FO, Monu JU, Snyder J: Juvenile dermatomyositis and polymyositis: a follow-up study of long-term sequelae. South Med J 1998, 91:17\u201322.","journal-title":"South Med J"},{"key":"7_CR13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1529-0131(200003)43:3<541::AID-ANR9>3.0.CO;2-T","volume":"43","author":"AM Huber","year":"2000","unstructured":"Huber AM, Lang B, LeBlanc CM, et al.: Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 2000, 43:541\u2013549. Good review of outcome studies.","journal-title":"Arthritis Rheum"},{"key":"7_CR14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1542\/peds.100.3.391","volume":"100","author":"DM Eisenstein","year":"1997","unstructured":"Eisenstein DM, Paller AS, Pachman LM: Juvenile dermatomyositis presenting with rash alone. Pediatrics 1997, 100:391\u2013392.","journal-title":"Pediatrics"},{"key":"7_CR15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0022-3476(84)80012-8","volume":"105","author":"CH Spencer","year":"1984","unstructured":"Spencer CH, Hanson V, Singsen BH, et al.: Course of treated juvenile dermatomyositis. J Pediatr 1984, 105:399\u2013408.","journal-title":"J Pediatr"},{"key":"7_CR16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-3476(64)80325-5","volume":"64","author":"S Bitnum","year":"1964","unstructured":"Bitnum S, Daeschner CW, Travis LB, Dodge WF, Hopps HC:Dermatomyositis. J Pediatr 1964, 64:101\u2013131.","journal-title":"J Pediatr"},{"key":"7_CR17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0140-6736(77)90716-4","volume":"ii","author":"LM Pachman","year":"1977","unstructured":"Pachman LM, Jonasson O, Cannon RA, et al.: Increased frequency of HLA-B8 in patients with juvenile dermatomyositis. Lancet 1977, ii:567\u2013568.","journal-title":"Lancet"},{"key":"7_CR18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1399-0039.1983.tb00371.x","volume":"21","author":"JM Friedman","year":"1983","unstructured":"Friedman JM, Pachman LM, Maryjowski ML, et al.:Immunogenetic studies of juvenile dermatomyositis: HLA antigens in patients and their families. Tissue Antigens 1983, 21:45\u201349.","journal-title":"Tissue Antigens"},{"key":"7_CR19","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/art.1780260216","volume":"26","author":"JM Friedman","year":"1983","unstructured":"Friedman JM, Pachman LM, Maryjowski ML, et al.:Immunogenetic studies of juvenile dermatomyositis: HLADR antigen frequencies. Arthritis Rheum 1983, 26:214\u2013216.","journal-title":"Arthritis Rheum"},{"key":"7_CR20","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/1529-0131(199707)40:7<1257::AID-ART10>3.0.CO;2-R","volume":"40","author":"I Hausmanowa-Petrusewicz","year":"1997","unstructured":"Hausmanowa-Petrusewicz I, Kowalska-Oledzka E, Miller FW, et al.: Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Arthritis Rheum 1997, 40:1257\u20131266.","journal-title":"Arthritis Rheum"},{"key":"7_CR21","first-page":"17","volume":"37","author":"P Vavrincova","year":"1993","unstructured":"Vavrincova P, Havelka S, Cerna M, Stastny P: HLA class II alleles in juvenile dermatomyositis. J Rheumatol (Suppl) 1993, 37:17\u201318.","journal-title":"J Rheumatol (Suppl)"},{"key":"7_CR22","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/1529-0131(199906)42:6<1285::AID-ANR28>3.0.CO;2-1","volume":"42","author":"LG Rider","year":"1999","unstructured":"Rider LG, Shamim E, Okada S, et al.: Genetic risk and protective factors for idiopathic inflammatory myopathy in Koreans and American whites: a tale of two loci. Arthritis Rheum 1999, 42:1285\u20131290.","journal-title":"Arthritis Rheum"},{"key":"7_CR23","first-page":"482","volume":"12","author":"EA Shamim","year":"2000","unstructured":"Shamim EA, Rider LG, Miller FW: Update on the genetics of the idiopathic inflammatory myopathies. Curr Opin Immunol 2000, 12:482\u2013491. Good review on genetics of idiopathic inflammatory myopathy.","journal-title":"Curr Opin Immunol"},{"key":"7_CR24","first-page":"S276","volume":"43","author":"AM Reed","year":"2000","unstructured":"Reed AM, Picornell J, Harwood A, Kredich DW: Chimerism in children with dermatomyositis. Arthritis Rheum 2000, 43:S276.","journal-title":"Arthritis Rheum"},{"key":"7_CR25","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/1529-0131(200009)43:9<2005::AID-ANR11>3.0.CO;2-#","volume":"43","author":"NC Lambert","year":"2000","unstructured":"Lambert NC, Evans PC, Hashizumi TL, et al.: Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunity. Arthritis Rheum 2000, 43:2005\u20132010.","journal-title":"Arthritis Rheum"},{"key":"7_CR26","first-page":"1000","volume":"25","author":"AM Reed","year":"1998","unstructured":"Reed AM, Pachman LM, Hayford JR, Ober C: Immunogenetic studies in families of children with juvenile dermatomyositis. J Rheumatol 1998, 25:1000\u20131002.","journal-title":"J Rheumatol"},{"key":"7_CR27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/hmg\/1.5.353","volume":"1","author":"AG Wilson","year":"1992","unstructured":"Wilson AG, diGiovine FS, Blakemore AIF, Duff GW: Single base polymorphism in the human tumor necrosis factor (TNFa) gene detected by NcoI restriction of PCR product. Hum Mol Genet 1992, 1:353.","journal-title":"Hum Mol Genet"},{"key":"7_CR28","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1073\/pnas.94.7.3195","volume":"94","author":"AG Wilson","year":"1997","unstructured":"Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW:Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. PNAS (USA) 1997, 94:3195\u20133199.","journal-title":"PNAS (USA)"},{"key":"7_CR29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/excr.1996.0368","volume":"229","author":"C Andre","year":"1996","unstructured":"Andre C, Guillemin MC, Zhu J, et al.: The PML and PML\/RAR alpha domains: from autoimmunity to molecular oncology and from retinoic acid to arsenic. Exp Cell Res 1996, 229:253\u2013260.","journal-title":"Exp Cell Res"},{"key":"7_CR30","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1046\/j.1365-2249.2000.01331.x","volume":"121","author":"A Caballero","year":"2000","unstructured":"Caballero A, Bravo MJ, Nieto A, et al.: TNFA promoter polymorphism and susceptibility to brucellosis. Clin Exp Immunol 2000, 121:480\u2013483.","journal-title":"Clin Exp Immunol"},{"key":"7_CR31","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1182\/blood.V91.10.3574","volume":"91","author":"K Warzocha","year":"1998","unstructured":"Warzocha K, Ribeiro P, Bienvenu J, et al.: Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin\u2019s lymphoma outcome. Blood 1998, 91:3574\u20133581.","journal-title":"Blood"},{"key":"7_CR32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/aid.1998.14.305","volume":"14","author":"MC Knuchel","year":"1998","unstructured":"Knuchel MC, Spira TJ, Neumann AU, et al.: Analysis of a biallelic polymorphism in the tumor necrosis factor alpha promoter and HIV type 1 disease progression. AIDS Res Hum Retrovir 1998, 14:305\u2013309.","journal-title":"AIDS Res Hum Retrovir"},{"key":"7_CR33","first-page":"3","volume":"56","author":"DRDSKDW Spriggs","year":"1992","unstructured":"Spriggs DRDSKDW: Genomic structure, induction, and production of TNF-alpha. Immunol Serol 1992, 56:3\u201334. Good review of control of TNFa production.","journal-title":"Immunol Serol"},{"key":"7_CR34","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0198-8859(99)00086-5","volume":"60","author":"H Obayashi","year":"1999","unstructured":"Obayashi H, Nakamura N, Fukui M, et al.: Influence of TNF microsatellite polymorphisms (TNFa) on age-at-onset of insulin-dependent diabetes mellitus. Hum Immunol 1999, 60:974\u2013978.","journal-title":"Hum Immunol"},{"key":"7_CR35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0960-8966(98)00126-6","volume":"9","author":"JL Bleeker","year":"1999","unstructured":"Bleeker JL, Meire VI, Declercq W, Van Aken EH:Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies. Neuromusc Disord 1999, 9:239\u2013246.","journal-title":"Neuromusc Disord"},{"key":"7_CR36","first-page":"1255","volume":"43","author":"TO Fedczyna","year":"2000","unstructured":"Fedczyna TO, Lutz JL, Caliendo J, Pachman LM: Expression of TNFa in muscle fibers in biopsies (MBx) from untreated juvenile dermatomyositis (JDM) is associated with the TNFa-308A allele. Arthritis Rheum 2000, 43, 1255-S276.","journal-title":"Arthritis Rheum"},{"key":"7_CR37","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1126\/science.8171316","volume":"264","author":"B Beutler","year":"1994","unstructured":"Beutler B, van Huffel C: Unraveling function in the TNF ligand and receptor families. Science 1994, 264:667\u2013668.","journal-title":"Science"},{"key":"7_CR38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0014-5793(91)80803-B","volume":"285","author":"W Fiers","year":"1991","unstructured":"Fiers W: Tumor necrosis factor: characterization at the molecular, cellular and in vivo level. FEBS Letters 1991, 285:199\u2013212. Good review of the early concepts of TNF.","journal-title":"FEBS Letters"},{"key":"7_CR39","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","volume":"15","author":"U Boehm","year":"1997","unstructured":"Boehm U, Klamp T, Groot M, Howard RF: Cellular responses to IFN-g. Annu Rev Immunol 1997, 15:749\u2013795.","journal-title":"Annu Rev Immunol"},{"key":"7_CR40","unstructured":"Tezak Z, Hoffman EP, Pachman LM: Expression profiling in untreated juvenile dermatomyositis. J Neurol 2001, In press."},{"key":"7_CR41","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S1286-4579(00)01282-X","volume":"2","author":"D Schluter","year":"2000","unstructured":"Schluter D, Deckert M: Divergent role of tumor necrosis factor receptors in infectious diseases. Microb Infect 2000, 2:1285\u20131292. Good review of TNF receptors.","journal-title":"Microb Infect"},{"key":"7_CR42","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/1097-0029(20000801)50:3<196::AID-JEMT3>3.0.CO;2-9","volume":"50","author":"MJ Smyth","year":"2000","unstructured":"Smyth MJ, Johnstone RW: Role of TNF in lymphocytemediated cytotoxicity. Microsc Res Tech 2000, 50:196\u2013208. Good review of the mechanism of action of TNF.","journal-title":"Microsc Res Tech"},{"key":"7_CR43","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1002\/1529-0131(199804)41:4<710::AID-ART19>3.0.CO;2-K","volume":"41","author":"LG Rider","year":"1998","unstructured":"Rider LG, Ahmed A, Beausang L, et al.: Elevations of interleukin-1 receptor antagonist (IL1RA), sTNFR, sIL2R and IL-10 in juvenile idiopathic inflammatory myopathies (JIIM) suggest a role for monocyte\/macrophage and B lymphocyte activation. Arthritis Rheum 1998, 41:S265.","journal-title":"Arthritis Rheum"},{"key":"7_CR44","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/1529-0131(199902)42:2<395::AID-ANR25>3.0.CO;2-K","volume":"42","author":"LM Pachman","year":"1999","unstructured":"Pachman LM, Mendez E, Lou H, et al.: Parent report of antecedent illness and environmental factors before onset of juvenile dermatomyositis (JDM): NIAMS JDM research registry data. Arthritis Rheum 1999, 42:395.","journal-title":"Arthritis Rheum"},{"key":"7_CR45","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/art.1780400822","volume":"40","author":"LM Pachman","year":"1997","unstructured":"Pachman LM, Hayford JR, Hochberg MC, et al.: New-onset juvenile dermatomyositis: comparisons with a healthy cohort and children with juvenile rheumatoid arthritis. Arthritis Rheum 1997, 40:1526\u20131533. Case-control study documenting increased infection in the 3 months before the first definite symptom of juvenile dermatomyositis.","journal-title":"Arthritis Rheum"},{"key":"7_CR46","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00005792-196607000-00001","volume":"45","author":"BQ Banker","year":"1966","unstructured":"Banker BQ, Victor M: Dermatomyositis (systemic angiopathy) of childhood. Medicine 1966, 45:261\u2013289. First histologic description of juvenile dermatomyositis.","journal-title":"Medicine"},{"key":"7_CR47","first-page":"1994","volume":"42","author":"LM Pachman","year":"1999","unstructured":"Pachman LM, Lingen M, Caliendo J, Kinder J, Chen EH: Muscle biopsy findings in 38 untreated children with juvenile dermatomyositis (JDM): capillary occlusion is associated with the TNF2 allele. Arthritis Rheum 1999, 42:1994-S403.","journal-title":"Arthritis Rheum"},{"key":"7_CR48","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/art.1780300513","volume":"30","author":"JP Scott","year":"1987","unstructured":"Scott JP, Arroyave C: Activation of complement and coagulation in juvenile dermatomyositis. Arthritis Rheum 1987, 30:572\u2013576.","journal-title":"Arthritis Rheum"},{"key":"7_CR49","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/clin.1997.4480","volume":"86","author":"AE Koch","year":"1998","unstructured":"Koch AE, Szekanecz Z, Friedman J, et al.: Effects of thrombospondin-1 on disease course and angiogenesis in rat adjuvant-induced arthritis. Clin Immunol Immunopath 1998, 86:199\u2013208.","journal-title":"Clin Immunol Immunopath"},{"key":"7_CR50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/jsre.1997.5209","volume":"74","author":"JJ Roth","year":"1998","unstructured":"Roth JJ, Gahtan V, Brown JL, et al.: Thrombospondin-1 is elevated with both intimal hyperplasia and hypercholesterolemia. J Surg Res 1998, 74:11\u201316.","journal-title":"J Surg Res"},{"key":"7_CR51","first-page":"652","volume":"43","author":"JL Lutz","year":"2000","unstructured":"Lutz JL, Fedczyna TO, Huwiler K, et al.: Increased plasma thrombospondin-1 (TSP-1) levels are associated with the TNFa-308A polymorphism in children with juvenile dermatomyositis (JDM). Arthritis Rheum 2000, 43, 652-S175.","journal-title":"Arthritis Rheum"},{"key":"7_CR52","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/1529-0131(200002)43:2<243::AID-ANR2>3.0.CO;2-K","volume":"43","author":"ML Miller","year":"2000","unstructured":"Miller ML, Mendez E, Klein-Gitelman MS, Pachman LM:Experience with etanercept in chronic juvenile dermatomyositis (JDM). Arthritis Rheum 2000, 43:1883.","journal-title":"Arthritis Rheum"},{"key":"7_CR53","first-page":"451","volume":"12","author":"G Cambridge","year":"1994","unstructured":"Cambridge G, Ovadia E, Isenberg DA, et al.: Juvenile dermatomyositis: serial studies of circulating autoantibodies to a 56kD nuclear protein. Clin Exp Rheumatol 1994, 12:451\u2013457.","journal-title":"Clin Exp Rheumatol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-996-0007-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-996-0007-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-996-0007-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T17:14:07Z","timestamp":1587575647000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-996-0007-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["7"],"URL":"https:\/\/doi.org\/10.1007\/s11926-996-0007-5","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}